Regenxbio hits Duchenne gene therapy milestone, eyes 2027 FDA approvalnews2026-05-14T11:00:17+00:00May 14th, 2026|Endpoints News|
BeOne’s next-gen BCL2 inhibitor wins FDA approval, taking aim at Venclextanews2026-05-14T10:31:51+00:00May 14th, 2026|Endpoints News|
Post-Hoc: Why FDA Commissioner Marty Makary was oustednews2026-05-13T14:46:37+00:00May 13th, 2026|Endpoints News|
Trump plans to fire Makary from FDA role, according to reportsnews2026-05-08T17:32:09+00:00May 8th, 2026|Endpoints News|
Atara, Pierre Fabre’s cell therapy to get another shot at FDA approvalnews2026-05-07T13:17:55+00:00May 7th, 2026|Endpoints News|
FDA search for new CBER head focused on small group of final candidatesnews2026-05-04T16:36:11+00:00May 4th, 2026|Endpoints News|
Moderna in talks with FDA over Phase 4 Covid vaccine datanews2026-05-01T18:08:48+00:00May 1st, 2026|Endpoints News|
FDA approves Pfizer and Arvinas’ breast cancer drug despite underwhelming datanews2026-05-01T17:33:49+00:00May 1st, 2026|Endpoints News|
TaeWoong Medical USA Receives FDA 510(k) Clearance for SPAXUS™, Expanding Its EUS Therapeutic Portfolionews2026-05-01T14:21:46+00:00May 1st, 2026|Medical Device News Magazine|
